Seres Therapeutics
MCRB
#8981
Rank
HK$0.74 B
Marketcap
HK$4.27
Share price
-3.90%
Change (1 day)
-25.20%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -HK$1.03 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -HK$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -HK$1.03 Billion34.63%
2023 -HK$0.76 Billion-59.97%
2022 -HK$1.9 Billion289.57%
2021 -HK$0.49 Billion-27.3%
2020 -HK$0.67 Billion23%
2019 -HK$0.55 Billion-30.11%
2018 -HK$0.78 Billion9.73%
2017 -HK$0.72 Billion-0.74%
2016 -HK$0.72 Billion70.96%
2015 -HK$0.42 Billion257.11%
2014 -HK$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.89 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.99 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$3.32 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA